Metadata Search
Page 1 of 1014 results
Sort by: relevance publication year Download as CSV

Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia

Journal Article published Jun 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 6 on pages 1024 to 1029

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases (U24-CA076518) | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | U.S. Department of Health and Human Services (HHSH250201200016C) | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Reinhold Munker, Ruta Brazauskas, Hai Lin Wang, Marcos de Lima, Hanna J. Khoury, Robert Peter Gale, Richard T. Maziarz, Brenda M. Sandmaier, Daniel Weisdorf, Wael Saber

Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial

Journal Article published Dec 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 12 on pages 2256 to 2263

Research funded by Novartis Pharmaceuticals Corporation | National Marrow Donor Program | National Cancer Institute (CA160684, 5U24-CA076518) | Patient-Centered Outcomes Research Institute | Roswell Park Cancer Institute | Takeda Oncology | Medical College of Wisconsin | Pfizer | Leukemia and Lymphoma Society | Alexion Pharmaceuticals | Otsuka Pharmaceutical Co, Ltd. – Japan | Fred Hutchinson Cancer Research Center | WellPoint | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Janssen Scientific Affairs, LLC | Gamida Cell Ltd. | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | National Heart, Lung, and Blood Institute (U10HL069294, N00014-15-1-0848, N00014-16-1-2020, 5U10HL069294) | Swedish Orphan Biovitrum, Inc. | Miltenyi Biotec | National Institutes of Health (UL1TR001436, KL2TR001438) | Optum Healthcare Solutions, Inc. | MesoScale Diagnostics, Inc. | HistoGenetics | Spectrum Pharmaceuticals | Genentech | National Center for Advancing Translational Sciences | Mesoblast | Genzyme | GmbH | Medac | Telomere Diagnostics, Inc. | Sunesis Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Health Research | Gilead Sciences | Otsuka America Pharmaceutical | Neovii Biotech NA, Inc. | Health Resources and Services Administration (HHSH250201200016C) | Cellular Dynamics International, Inc. | Celgene | AstraZeneca | Merck | MedImmune | St. Baldrick's Foundation | Be The Match Foundation | Amgen | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | Bluebird Bio, Inc. | Astellas Pharma US | Incyte Corporation | Bristol-Myers Squibb Foundation

Authors: Jennifer M. Knight, Karen L. Syrjala, Navneet S. Majhail, Michael Martens, Jennifer Le-Rademacher, Brent R. Logan, Stephanie J. Lee, Paul B. Jacobsen, William A. Wood, Heather S.L. Jim, John R. Wingard, Mary M. Horowitz, Muneer H. Abidi, Mingwei Fei, Laura Rawls, J. Douglas Rizzo

Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations

Journal Article published Apr 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 4 on pages 744 to 751

Research funded by Novartis Pharmaceuticals Corporation | National Marrow Donor Program | National Cancer Institute (5U24-CA076518) | U.S. Public Health Service | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | Medical College of Wisconsin | Pharmacyclics | TerumoBCT | Leukemia and Lymphoma Society | Bristol-Myers Squibb | Therakos | Alexion Pharmaceuticals | Fred Hutchinson Cancer Research Center | WellPoint | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Gamida Cell Ltd. | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | National Heart, Lung, and Blood Institute (5U10HL069294) | Swedish Orphan Biovitrum, Inc. | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Optum Healthcare Solutions, Inc. | HistoGenetics | Spectrum Pharmaceuticals | Genentech | Mesoblast | Genzyme | Telomere Diagnostics, Inc. | Sunesis Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Health Research | Gilead Sciences | Otsuka America Pharmaceutical | Neovii Biotech NA, Inc. | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Be The Match Foundation | Oxford Immunotec | Amgen | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Otsuka Pharmaceutical

Authors: Junya Kanda, Ruta Brazauskas, Zhen-Huan Hu, Yachiyo Kuwatsuka, Koji Nagafuji, Heiwa Kanamori, Yoshinobu Kanda, Koichi Miyamura, Makoto Murata, Takahiro Fukuda, Hisashi Sakamaki, Fumihiko Kimura, Sachiko Seo, Mahmoud Aljurf, Ayami Yoshimi, Giuseppe Milone, William A. Wood, Celalettin Ustun, Shahrukh Hashimi, Marcelo Pasquini, Carmem Bonfim, Jignesh Dalal, Theresa Hahn, Yoshiko Atsuta, Wael Saber

New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation

Journal Article published Apr 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 4 on pages 768 to 770

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (HHSH250201200016C) | U.S. Public Health Service (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (N00014-13-1-0039, N00014-14-1-0028) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Institutional Research | Milliman | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | American Cancer Society (86-004-26) | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Anita D'Souza, Jiaxing Huang, Parameswaran Hari

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission

Journal Article published 24 Jan 2017 in Cancer volume 123 issue 11 on pages 2025 to 2034

Research funded by Novartis Pharmaceuticals Corporation | National Marrow Donor Program | National Cancer Institute (HHSH250201200016C) | Patient-Centered Outcomes Research Institute | Merck & Company, Inc. | Roswell Park Cancer Institute | Takeda Oncology | Medical College of Wisconsin | Leukemia and Lymphoma Society | Spectrum Pharmaceuticals, Inc. | Pfizer, Inc | Alexion Pharmaceuticals | Fred Hutchinson Cancer Research Center | WellPoint | Seattle Genetics | National Institute of Allergy and Infectious Diseases (grant/cooperative agreement 5U10HL069294) | Janssen Scientific Affairs, LLC | Center for International Blood and Marrow Transplantation (CIBMTR) | Sanofi US | Bristol Myers Squibb Oncology | Gamida Cell Ltd. | University of Minnesota | Perkin Elmer, Inc. | Otsuka Pharmaceutical Company, Ltd.-Japan | Onyx Pharmaceuticals | National Heart, Lung, and Blood Institute | Swedish Orphan Biovitrum, Inc. | Bluebird Bio, Inc | Optum Healthcare Solutions, Inc. | MesoScale Diagnostics, Inc. | Genentech | Mesoblast | Genzyme | Medac, GmbH | Miltenyi Biotec, Inc. | Public Health Service (grant/cooperative agreement 5U24-CA076518) | Telomere Diagnostics, Inc. | Sunesis Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Health Research | Gilead Sciences | Otsuka America Pharmaceutical | Neovii Biotech NA, Inc. | Health Resources and Services Administration (N00014-15-1-0848, N00014-16-1-2020) | Cellular Dynamics International, Inc. | Celgene | AstraZeneca | MedImmune | St. Baldrick's Foundation | Be The Match Foundation | Amgen | HistoGenetics, Inc. | Sunesis Pharmaceuticals | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | Astellas Pharma US | Incyte Corporation

Authors: Daniel J. Weisdorf, Heather R. Millard, Mary M. Horowitz, Parvinder S. Hyare, Richard Champlin, Vincent Ho, Marco Mielcarek, Andrew Rezvani, Keith Stockerl-Goldstein, Hanna J. Khoury, Marcos De Lima, Wael Saber, Brenda Sandmaier, Mei Jie Zhang, Mary Eapen

Carfilzomib–dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR study

Journal Article published 22 Sep 2017 in Leukemia & Lymphoma volume 59 issue 6 on pages 1364 to 1374

Research funded by Onyx Pharmaceuticals | Amgen | BlueMomentum | Ashfield Company | UDG Healthcare plc

Authors: Hartmut Goldschmidt, Philippe Moreau, Heinz Ludwig, Ruben Niesvizky, Wee-Joo Chng, Douglas Joshua, Katja Weisel, Andrew Spencer, Robert Z. Orlowski, Shibao Feng, Karim S. Iskander, Meletios A. Dimopoulos

Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation

Journal Article published 15 Mar 2016 in British Journal of Haematology volume 174 issue 2 on pages 235 to 248

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Sanofi US | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Genzyme | Miltenyi Biotec, Inc. | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Tarix Pharmaceuticals | Amgen | HistoGenetics, Inc. | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Timothy S. Fenske, Kwang W. Ahn, Tara M. Graff, Alyssa DiGilio, Qaiser Bashir, Rammurti T. Kamble, Ernesto Ayala, Ulrike Bacher, Jonathan E. Brammer, Mitchell Cairo, Andy Chen, Yi-Bin Chen, Saurabh Chhabra, Anita D'Souza, Umar Farooq, Cesar Freytes, Siddhartha Ganguly, Mark Hertzberg, David Inwards, Samantha Jaglowski, Mohamed A. Kharfan-Dabaja, Hillard M. Lazarus, Sunita Nathan, Attaphol Pawarode, Miguel-Angel Perales, Nishitha Reddy, Sachiko Seo, Anna Sureda, Sonali M. Smith, Mehdi Hamadani

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis

Journal Article published Jun 2018 in Biology of Blood and Marrow Transplantation volume 24 issue 6 on pages 1163 to 1171

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases (5U10HL069294, HHSH250201200016C) | Sanofi US | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Genzyme | Teva Neuroscience, Inc. | Public Health Service (U24-CA076518) | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (N00014-13-1-0039, N00014-14-1-0028)) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | HistoGenetics, Inc. | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Karyopharm Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Carla Casulo, Jonathan W. Friedberg, Kwang W. Ahn, Christopher Flowers, Alyssa DiGilio, Sonali M. Smith, Sairah Ahmed, David Inwards, Mahmoud Aljurf, Andy I. Chen, Hannah Choe, Jonathon Cohen, Edward Copelan, Umar Farooq, Timothy S. Fenske, Cesar Freytes, Sameh Gaballa, Siddhartha Ganguly, Yogesh Jethava, Rammurti T. Kamble, Vaishalee P. Kenkre, Hillard Lazarus, Aleksandr Lazaryan, Richard F. Olsson, Andrew R. Rezvani, David Rizzieri, Sachiko Seo, Gunjan L. Shah, Nina Shah, Melham Solh, Anna Sureda, Basem William, Aaron Cumpston, Andrew D. Zelenetz, Brian K. Link, Mehdi Hamadani

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

Journal Article published 8 Aug 2017 in British Journal of Haematology volume 179 issue 1 on pages 98 to 105

Research funded by Pfizer | AbbVie | Acerta Pharma | Bristol-Myers Squibb | Novartis | Seattle Genetics | Sanofi | Millennium | Pharmacyclics, Inc | Onyx Pharmaceuticals | Prothena | Alnylam Pharmaceuticals | Spectrum Pharmaceuticals | Ionis Pharmaceuticals | Celldex | Janssen Pharmaceuticals | Celgene | Merck | Takeda Pharmaceuticals North America | Amgen | Karyopharm Therapeutics | Affimed

Authors: Jonas Paludo, Jithma P. Abeykoon, Shaji Kumar, Amanda Shreders, Sikander Ailawadhi, Morie A. Gertz, Taxiarchis Kourelis, Rebecca L. King, Craig B. Reeder, Nelson Leung, Robert A. Kyle, Francis K. Buadi, Thomas M. Habermann, David Dingli, Thomas E. Witzig, Angela Dispenzieri, Martha Q. Lacy, Ronald S. Go, Yi Lin, Wilson I. Gonsalves, Rahma Warsame, John A. Lust, S. Vincent Rajkumar, Stephen M. Ansell, Prashant Kapoor

Carfilzomib as salvage therapy in Waldenstrom macroglobulinemia: a case series

Journal Article published 5 Jun 2017 in Leukemia & Lymphoma volume 59 issue 1 on pages 259 to 261

Research funded by Onyx Pharmaceuticals | Amgen

Authors: David H. Vesole, Joshua Richter, Noa Biran, Laura McBride, Palka Anand, Mei Huang, Anita-Zahlten Kumeli, Zandra Klippel, Karim Iskander, David S. Siegel